See also this year's filing and all EDGAR filings for this company.
PDF Report 0001445499_2023_IMPEL_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001445499, IMPEL PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 79,809,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,863,000 |
| 3 | remainder_Assets | 4,878,000 |
| 4 | LiabilitiesCurrent | 22,163,000 |
| 5 | LiabilitiesNoncurrent | 49,645,000 |
| 6 | remainder_Liabilities | 60,899,000 |
| 7 | CostOfGoodsAndServicesSold | 6,495,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 77,885,000 |
| 9 | ResearchAndDevelopmentExpense | 11,456,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 12,652,000 |
| 12 | remainder_NetIncome | -23,128,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 88,550,000 |
| 1 | Liabilities | 132,707,000 |
| 2 | Expenses | 95,836,000 |
| 3 | Revenues | 12,652,000 |
| 4 | StockholdersEquity | -44,157,000 |
| 5 | NetIncome | -106,312,000 |
| 6 | ComprehensiveNetIncome | -106,312,000 |
| 7 | BaseVar | 176,436,500 |
| 8 | EconomicCapitalRatio | -1.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
